LOCALLY ADVANCED CERVICAL CANCER
Clinical trials for LOCALLY ADVANCED CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CERVICAL CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could keep cervical cancer away after chemoradiation
Disease control Recruiting nowThis phase 3 trial is testing an immunotherapy drug called volrustomig in 800 women with high-risk locally advanced cervical cancer who have finished chemoradiation. The goal is to see if volrustomig can keep the cancer from coming back or improve survival compared to a placebo. …
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a 3-Week radiation course beat the standard 5-Week for cervical cancer?
Disease control Recruiting nowThis study tests whether a shorter, 3-week course of radiation works as well as the standard 5-week course for women with locally advanced cervical cancer. About 396 women will be randomly assigned to one of the two schedules, both combined with chemotherapy. If the shorter sched…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: NA • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Dual immunotherapy plus chemo may shrink cervical tumors before surgery
Disease control Recruiting nowThis phase 2 trial is testing a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus standard chemotherapy before surgery in 103 women with locally advanced cervical cancer. The goal is to see if this approach can shrink tumors enough to allow less extensive…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo aims to boost cervical cancer treatment
Disease control Recruiting nowThis Phase 3 trial tests whether adding the immunotherapy drug cadonilimab to standard chemotherapy and radiation can improve outcomes for people with locally advanced cervical cancer. About 378 participants will be randomly assigned to receive either the new combination or stand…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a special shake help cervical cancer patients tolerate chemo better?
Disease control Recruiting nowThis study tests whether a special nutritional drink (immunonutrition) can help malnourished cervical cancer patients better tolerate chemotherapy and improve their quality of life. Fifty patients receiving standard chemoradiation will be randomly assigned to get either the speci…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: NA • Sponsor: SHUANG ZHENG JIA, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug cocktail shows promise for cervical cancer before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether giving a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) along with chemotherapy before surgery can help shrink tumors in people with locally advanced cervical cancer. The study will enroll 43 participants and measure ho…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:30 UTC
-
New nanocrystal drug aims to fight cancer wasting during chemoradiation
Symptom relief Recruiting nowThis early-stage trial tests a new, easier-to-absorb version of megestrol acetate (a drug that stimulates appetite) in 5 women with advanced cervical cancer who are undergoing chemoradiation. The goal is to see if it helps them maintain weight and improve nutrition during treatme…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE1 • Sponsor: Second Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
One-Week radiation could ease pain for advanced cervical cancer patients
Symptom relief Recruiting nowThis study compares a fast, 1-week radiation treatment to a standard 6-8 week schedule for reducing pain in people with advanced cervical cancer that cannot be cured. The goal is to see if the shorter schedule provides similar or better pain relief. The trial is recruiting 230 pa…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: NA • Sponsor: Tata Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Protein clues may predict cervical cancer return
Knowledge-focused Recruiting nowThis study is looking at 180 women with advanced cervical cancer who were treated with radiation and chemotherapy. Researchers want to see if high levels of certain proteins (called IAPs) in the original tumor biopsy can predict whether the cancer will come back within two years.…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists track Cancer's inner workings during radiation treatment
Knowledge-focused Recruiting nowThis study is for people with cervical or pancreatic cancer who are scheduled to receive chemoradiotherapy. Researchers will collect tumor samples, blood, and imaging data before, during, and after treatment to see how the tumor environment changes over time. The goal is to learn…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC